Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals

GLAXO

 ₹ 2,732.01
 ₹ 44.93
1.67%
Healthcare
 ₹ 2,732.01
44.93(1.67%)1D
Updated: 11 Oct 2024, 03:32:30 pm IST
Stock Score
Open Price
 ₹ 2,729.07
Prev. Close
 ₹ 2,687.08
 ₹ 2,677.43
Day Low
 ₹ 2,800.34
Day High

 ₹ 1,357.81
52 Week Low
 ₹ 3,252.01
52 Week High

Quick Bite

Price To Earnings Ratio

78.44

Sector PE

62.05

PB Ratio

25.90

Sector PB

9.13

EPS

34.83

Dividend Yield

1.65

Today's Volume

62.239 K

5 Day Avg. Volume

84.938 K

PEG Ratio

-23.14

Market Cap.

₹ 46,610.00 Cr.

Returns Comparison

TimeGLAXOVSIndustry
1 Day1.67%1.58%
1 Week0.61%2.11%
1 Month-2.96%-1.21%
6 Months33.94%21.8%
1 Year72.01%60.95%

StockGro Trade Views 👍

StockGro Trade Views 👍

Technical Trend

Bearish
academy home
Bearish
Neutral
Bullish

Pivot Levels

R3 ₹ 2,918.67
R2 ₹ 2,859.50
R1 ₹ 2,795.76
RESISTANCE
 ₹ 2,736.59
SUPPORT
S1 ₹ 2,672.85
S2 ₹ 2,613.68
S3 ₹ 2,549.94

Updated: 22 Jul 2024,09:18:33 am IST

Moving Averages

Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
4
Buy
2
Period (Days)SMAIndication
102734.71Bearish
202749.11Bearish
302774.29Bearish
502809.43Bearish
1002692.28Bullish
2002392.21Bullish

Updated: 11 Oct 2024, 03:30:00 pm IST

Analyst Rankings 👍

Analyst Rankings 👍

Shareholding Updates

PromotersPublicDIIFIIOthers
75%
Promoters
Sep 2024
Promoters  75%
FII  4.36%
DII  7.33%
Public  13.3%
Others  0.01%

Mutual Fund Ownership 👍

Mutual Fund Ownership 👍

Cash Flow

AnnualFY 2024FY 2023FY 2022
Operating Activities582.02484.23810.75
Investing Activities8.71807.85-405.51
Financing Activities-561.50-1543.32-524.24
Net Cash Flow29.23-251.25-119.00

All Figures in ₹ Cr., unless mentioned otherwise

Ratios

Return on Equity (%)

Income Statement

All Figures in ₹ Cr., unless mentioned otherwise

Balance Sheet

All Figures in ₹ Cr., unless mentioned otherwise

Peer Comparison

Name1D (%)1W (%)1M (%)6M (%)1Y (%)
Glaxosmithkline Pharmaceuticals1.670.61-2.9633.9472.01
Alembic0.98-1.34-9.763.713.71
Aurobindo Pharma4.212.560.0722.5463.22
Fortis Healthcare-3.822.444.1625.982.15
Ajanta Pharmaceuticals-0.160.4-1.1145.5388.12
Returns as on 13 Oct, 2024

About Glaxosmithkline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

Glaxosmithkline Pharmaceuticals Share Price

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The company's field of activity is the production, distribution and trade of medicines. It produces drugs used in the pharmaceutical industry, such as antibiotics, endocrine products, essential vitamins; opium derivatives; sulfa drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and plant alkaloids and chemically pure sugar. It offers a variety of prescription drugs, vaccines and consumer health products. Its drug portfolio includes Adartrel, Bactroban, Combodart and Duodart. Its vaccine portfolio includes Ambirix, Cervarix, Fendrix and Havrix. The company's products include betamethasone, clavulanate potassium with amoxicillin, and pneumococcal polysaccharide and conjugate vaccine. Its oral care products include Sensodyne, parodontax and Polident. Its manufacturing unit is located in Nashik.

Glaxosmithkline Pharmaceuticals FAQs

How to Buy Glaxosmithkline Pharmaceuticals Share?

virtual
To purchase Glaxosmithkline Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) on the trading platform provided by your broker and purchase the shares.

What's Glaxosmithkline Pharmaceuticals share price today?

virtual
The stock price of Glaxosmithkline Pharmaceuticals as of 12 Oct 2024 is ₹2,732.01

What is the Market Cap of Glaxosmithkline Pharmaceuticals?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 12 Oct 2024, Glaxosmithkline Pharmaceuticals (ticker symbol: GLAXO) has a market capitalisation of approximately ₹0.00

What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals?

virtual
Glaxosmithkline Pharmaceuticals Ltd's price-to-book ratio as of 12 Oct 2024 is 0, reflecting the market's valuation compared to its asset value. As of 12 Oct 2024, the trailing twelve months P/E (price-to-earnings) ratio is 0, indicating the market values the company at around ₹0.00 for every ₹1 of earnings

What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Share?

virtual
Glaxosmithkline Pharmaceuticals Ltd (GLAXO) hit its 52-week high at ₹0.00, and its 52-week low at { ₹0.00}.
Want to learn and earn in Stocks?
Login/Register
Start Learning